Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (7643)	5/9/1999 12:42:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Pfizer's Viagra to Be Prescribed More Widely in UK London, May 7 (Bloomberg) -- The U.K. government will relax restrictions on doctors prescribing Pfizer Inc.'s anti-impotence drug Viagra on the state-run National Health Service (NHS), Health Secretary Frank Dobson said. The public health insurer will pay for Viagra prescriptions for men with 10 more medical conditions. Last year, the government ruled that NHS doctors could only prescribe the drug for a restricted list of uses. The new rules will apply from July 1. The original ruling was made because the government feared the cost of prescribing the drug would run out of control, and sought to restrain Viagra expenses to within 12 million pounds ($19 million) a year. After criticism of this earlier decision, Dobson consulted with doctors and other interested parties and said today he'll now extend the list of eligible men to include those with prostate cancer, spinal injury, kidney failure, diabetes, multiple sclerosis, spina bifida, polio, Parkinson's disease and other conditions. The government had no immediate estimate of how many patients the new ruling would affect or how much money it would cost.